{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:44:41Z","timestamp":1783489481298,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,8,14]],"date-time":"2005-08-14T00:00:00Z","timestamp":1123977600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Susceptibility to beryllium (Be)-hypersensitivity (BH) has been associated with HLA-DP alleles carrying a glutamate at position 69 of the HLA-DP \u03b2-chain (HLA-DPGlu69) and with several HLA-DP, -DQ and -DR alleles and polymorphisms. However, no genetic associations have been found between BH affected subjects not carrying the HLA-DPGlu69 susceptibility marker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this report, we re-evaluated an already described patient populations after 7 years of follow-up including new 29 identified BH subjects. An overall population 36 berylliosis patients and 38 Be-sensitization without lung granulomas and 86 Be-exposed controls was analysed to assess the role of the individual HLA-class II polymorphisms associated with BH-susceptibility in HLA-DPGlu69 negative subjects by univariate and multivariate analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>As previously observed in this population the HLA-DPGlu69 markers was present in higher frequency in berylliosis patients (31 out of 36, 86%) than in Be-sensitized (21 out of 38, 55%, p = 0.008 vs berylliosis) and 41 out of 86 (48%, p &lt; 0.0001 vs berylliosis, p = 0.55 vs Be-sensitized) Be-exposed controls.<\/jats:p><jats:p>However, 22 subjects presenting BH did not carry the HLA-DPGlu69 marker. We thus evaluated the contribution of all the HLA-DR, -DP and -DQ polymorphisms in determining BH susceptibility in this subgroup of HLA-Glu69 subjects. In HLA-DPGlu69-negatives a significant association with BH was found for the HLA-DQLeu26, for the HLA-DRB1 locus residues Ser13, Tyr26, His32, Asn37, Phe47 and Arg74 and for the HLA-DRB3 locus clusterized residues Arg11, Tyr26, Asp28, Leu38, Ser60 and Arg74. HLA-DRPhe47 (OR 2.956, p &lt; 0.05) resulting independently associated with BH. Further, Be-stimulated T-cell proliferation in the HLA-DPGlu69-negative subjects (all carrying HLA-DRPhe47) was inhibited by the anti-HLA-DR antibody (range 70\u201392% inhibition) significantly more than by the anti-HLA-DP antibody (range: 6\u201329%; p &lt; 0.02 compared to anti-HLA-DR) while it was not affected by the anti-HLA-DQ antibody.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We conclude that HLA-DPGlu69 is the primary marker of Be-hypersensitivity and HLA-DRPhe47 is associated with BH in Glu69-negative subjects, likely playing a role in Be-presentation and sensitization.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1465-9921-6-94","type":"journal-article","created":{"date-parts":[[2005,8,17]],"date-time":"2005-08-17T06:13:54Z","timestamp":1124259234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of HLA-DRPhe\u03b247 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlu\u03b269"],"prefix":"10.1186","volume":"6","author":[{"given":"Massimo","family":"Amicosante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"van den Berg-Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Saltini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,8,14]]},"reference":[{"key":"332_CR1_332","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/clin.1994.1061","volume":"71","author":"K Kreiss","year":"1994","unstructured":"Kreiss K, Miller F, Newman L, Ojo-Amaize EA, Rossman M, Saltini C: Chronic beryllium disease. From the workplace to cellular immunology, molecular immunogenetics, and back. Clin Immunol Immunopath 1994, 71:123\u2013129.","journal-title":"Clin Immunol Immunopath"},{"key":"332_CR2_332","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","volume":"108","author":"MD Rossman","year":"1988","unstructured":"Rossman MD, Kern JA, Elias LA, Cullen MR, Epstein PE, Preuss OP, Markham TN, Daniele RP: Proliferative response of bronchoalveolar lymphocytes to beryllium. Ann Int Med 1988, 108:687\u2013693.","journal-title":"Ann Int Med"},{"key":"332_CR3_332","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1006\/clim.2001.5053","volume":"100","author":"AP Fontenot","year":"2001","unstructured":"Fontenot AP, Newman LS, Kotzin BL: Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. Clin Immunol 2001, 100:4\u201314.","journal-title":"Clin Immunol"},{"key":"332_CR4_332","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","volume":"320","author":"C Saltini","year":"1989","unstructured":"Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG: Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 1989, 320:1103\u20131109.","journal-title":"N Engl J Med"},{"key":"332_CR5_332","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.171.4.1123","volume":"171","author":"C Saltini","year":"1990","unstructured":"Saltini C, Kirby M, Trapnell B, Tamura N, Crystal RG: Biased accumulation of T-lymphocytes with \"memory\"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human hung. J Exp Med 1990, 171:1123\u20131140.","journal-title":"J Exp Med"},{"key":"332_CR6_332","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI0215846","volume":"110","author":"AP Fontenot","year":"2002","unstructured":"Fontenot AP, Canavera SJ, Gharavi L, Newman LS, Kotzin BL: Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest 2002, 110:1473\u20131482.","journal-title":"J Clin Invest"},{"key":"332_CR7_332","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.8105536","volume":"262","author":"L Richeldi","year":"1993","unstructured":"Richeldi L, Sorrentino R, Saltini C: HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993, 262:242\u2013244.","journal-title":"Science"},{"key":"332_CR8_332","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","volume":"32","author":"L Richeldi","year":"1997","unstructured":"Richeldi L, Kreiss K, Mroz MM, Zhen B, Tartoni P, Saltini C: Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 1997, 32:337\u2013340.","journal-title":"Am J Ind Med"},{"key":"332_CR9_332","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","volume":"163","author":"Z Wang","year":"1999","unstructured":"Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL: Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol 1999, 163:1647\u20131653.","journal-title":"J Immunol"},{"key":"332_CR10_332","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1183\/09031936.01.00106201","volume":"18","author":"C Saltini","year":"2001","unstructured":"Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C: Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 2001, 18:677\u2013684.","journal-title":"Eur Respir J"},{"key":"332_CR11_332","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0300-483X(01)00410-3","volume":"165","author":"Z Wang","year":"2001","unstructured":"Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL: Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 2001, 165:27\u201338.","journal-title":"Toxicology"},{"key":"332_CR12_332","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","volume":"165","author":"MD Rossman","year":"2002","unstructured":"Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D: Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 2002, 165:788\u2013794.","journal-title":"Am J Respir Crit Care Med"},{"key":"332_CR13_332","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","volume":"171","author":"LA Maier","year":"2003","unstructured":"Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS: Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 2003, 171:6910\u20136918.","journal-title":"J Immunol"},{"key":"332_CR14_332","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ajim.20045","volume":"46","author":"EC McCanlies","year":"2004","unstructured":"McCanlies EC, Ensey JS, Schuler CR, Kreiss K, Weston A: The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 2004, 46:95\u2013103.","journal-title":"Am J Ind Med"},{"key":"332_CR15_332","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.4049\/jimmunol.166.5.3549","volume":"166","author":"G Lombardi","year":"2001","unstructured":"Lombardi G, Germain C, Uren J, Fiorillo MT, du Bois RM, Jones-Williams W, Saltini C, Sorrentino R, Lechler R: HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol 2001, 166:3549\u20133555.","journal-title":"J Immunol"},{"key":"332_CR16_332","doi-asserted-by":"publisher","first-page":"12717","DOI":"10.1073\/pnas.220430797","volume":"97","author":"AP Fontenot","year":"2000","unstructured":"Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL: Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A 2000, 97:12717\u201312722.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"332_CR17_332","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0198-8859(01)00261-0","volume":"62","author":"M Amicosante","year":"2001","unstructured":"Amicosante M, Sanarico N, Berretta F, Arroyo J, Lombardi G, Lechler R, Colizzi V, Saltini C: Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum Immunol 2001, 62:686\u2013693.","journal-title":"Hum Immunol"},{"key":"332_CR18_332","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1183\/09031936.02.02232001","volume":"20","author":"M Amicosante","year":"2002","unstructured":"Amicosante M, Berretta F, Franchi A, Rogliani P, Dotti C, Losi M, Dweik R, Saltini C: HLA-DP-unrestricted TNF-\u03b1 release in beryllium-stimulated peripheral blood mononuclear cells. Eur Respir J 2002, 20:1174\u20131178.","journal-title":"Eur Respir J"},{"key":"332_CR19_332","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ajim.20082","volume":"46","author":"AW Stange","year":"2004","unstructured":"Stange AW, Furman FJ, Hilmas DE: The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med 2004, 46:453\u2013462.","journal-title":"Am J Ind Med"},{"key":"332_CR20_332","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1128\/iai.60.9.3925-3927.1992","volume":"60","author":"S Khanolkar-Young","year":"1992","unstructured":"Khanolkar-Young S, Kolk AH, Andersen AB, Bennedsen J, Brennan PJ, Rivoire B, Kuijper S, McAdam KP, Abe C, Batra HV: Results of the third immunology of leprosy\/immunology of tuberculosis antimycobacterial monoclonal antibody workshop. Infect Immun 1992, 60:3925\u20133927.","journal-title":"Infect Immun"},{"key":"332_CR21_332","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1086\/378097","volume":"73","author":"MD Rossman","year":"2003","unstructured":"Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, Monos D, ACCESS group: HLA-DRB1*1101: a significant factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003, 73:720\u2013735.","journal-title":"Am J Hum Genet"},{"key":"332_CR22_332","first-page":"621","volume":"11","author":"J Rozas","year":"1995","unstructured":"Rozas J, Rozas R: DnaSP, DNA sequence polymorphism: an interactive program for estimating population genetics parameters from DNA sequence data. Comput Appl Biosci 1995, 11:621\u2013625.","journal-title":"Comput Appl Biosci"},{"key":"332_CR23_332","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","volume":"171","author":"LS Newman","year":"2005","unstructured":"Newman LS, Mroz MM, Balkissoon R, Maier LA: Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 2005, 171:54\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"332_CR24_332","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0198-8859(92)90023-G","volume":"34","author":"MA Degli-Esposti","year":"1992","unstructured":"Degli-Esposti MA, Leaver AL, Christiansen FT, Witt CS, Abraham LJ, Dawkins RL: Ancestral haplotypes: conserved population MHC haplotypes. Hum Immunol 1992, 34:242\u2013252.","journal-title":"Hum Immunol"},{"key":"332_CR25_332","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/0167-5699(93)90200-5","volume":"14","author":"BD Evavold","year":"1993","unstructured":"Evavold BD, Sloan-Lancaster J, Allen PM: Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 1993, 14:602\u2013609.","journal-title":"Immunol Today"},{"key":"332_CR26_332","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.4049\/jimmunol.152.4.1709","volume":"152","author":"LM Spain","year":"1994","unstructured":"Spain LM, Jorgensen JL, Davis MM, Berg LJ: A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol 1994, 152:1709\u20131717.","journal-title":"J Immunol"},{"key":"332_CR27_332","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2140::AID-IMMU2140>3.0.CO;2-Q","volume":"29","author":"I Potolicchio","year":"1999","unstructured":"Potolicchio I, Festucci A, Hausler P, Sorrentino R: HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. Eur J Immunol 1999, 29:2140\u20132147.","journal-title":"Eur J Immunol"},{"key":"332_CR28_332","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1084\/jem.20021762","volume":"197","author":"L Lu","year":"2003","unstructured":"Lu L, Vollmer J, Moulon C, Weltzien HU, Marrack P, Kappler J: Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med 2003, 197:567\u2013574.","journal-title":"J Exp Med"},{"key":"332_CR29_332","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/364033a0","volume":"364","author":"JH Brown","year":"1993","unstructured":"Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993, 364:33\u201339.","journal-title":"Nature"},{"key":"332_CR30_332","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/378457a0","volume":"378","author":"P Ghosh","year":"1995","unstructured":"Ghosh P, Amaya M, Mellins E, Wiley DC: The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995, 378:457\u2013464.","journal-title":"Nature"},{"key":"332_CR31_332","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1074-7613(00)80369-6","volume":"7","author":"A Dessen","year":"0101","unstructured":"Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC: X-ray crystal structure of HLA-DR4 (DRA* DRB1*0401) complexed with a peptide from human collagen II. Immunity 0101, 7:473\u2013481.","journal-title":"Immunity"},{"key":"332_CR32_332","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1084\/jem.188.8.1511","volume":"188","author":"KJ Smith","year":"0101","unstructured":"Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW: Crystal structure of HLA-DR2 (DRA* DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med 0101, 188:1511\u20131520.","journal-title":"J Exp Med"},{"key":"332_CR33_332","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.272.5264.1001","volume":"272","author":"DH Fremont","year":"1996","unstructured":"Fremont DH, Hendrickson WA, Marrack P, Kappler J: Structures of an MHC class II molecule with covalently bound single peptides. Science 1996, 272:1001\u20131004.","journal-title":"Science"},{"key":"332_CR34_332","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","volume":"17","author":"T Sturniolo","year":"1999","unstructured":"Sturniolo T, Bono E, Ding J, Raddrizzani L, Tuereci O, Sahin U, Braxenthaler M, Gallazzi F, Protti MP, Sinigaglia F, Hammer J: Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999, 17:555\u2013561.","journal-title":"Nat Biotechnol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-94.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-6-94\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-94","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-6-94.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T06:47:43Z","timestamp":1683182863000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-6-94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,14]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["332"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-6-94","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,14]]},"assertion":[{"value":"31 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"94"}}